Additional studies have developed a cuproptosis-related signature with six genes (MTF1, DKN2A, PDHA1, DLD, LIPT1, FDX1) for breast cancer, which accurately predicted the OS rate (Jiang B et al., 2022). The gene discussed is FDX1; the disease is breast cancer.